1Naganuma T,Chieffo A,Meliga E,et al.Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery:the DELTA Registry(drug-eluting stent for left main coronary artery disease):a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment[J].JACC Cardiovasc Interv,2013,6(12):1242-1249.
2Chieffo A,Meliga E,Latib A,et al.Drug-eluting stent for left main coronary artery disease.The DELTA registry:a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment[J].JACC Cardiovasc Interv,2012,5(7):718-727.
3Trenk D,Stone GW,Gawaz M,et al.A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents:results of the TRIGGER-PCI(Testing Platelet Reactivity in Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study[J].J Am Coll Cardiol,2012,59(24):2159-2164.
4Meliga E,De Benedictis M,Gagnor A,et al.Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old[J].Am J Cardiol,2012,109(12):1717-1721.
5Legutko J,Jakala J,Mintz GS,et al.Virtual histology-intravascular ultrasound assessment of lesion coverage after angiographically-guided stent implantation in patients with ST Elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Am J Cardiol,2012,109(10):1405-1410.
6Sethi A,Bahekar A,Bhuriya R,et al.Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention:a meta-analysis of randomized trials[J].Arch Cardiovasc Dis,2012,105(11):544-556.
